01.12.2016 | Research article | Ausgabe 1/2016 Open Access

Incidence and excess mortality of hip fracture in young adults: a nationwide population-based cohort study
- Zeitschrift:
- BMC Musculoskeletal Disorders > Ausgabe 1/2016
Electronic supplementary material
Background
Methods
Data source and subjects
Outcome measures
Statistical analysis
Results
Total
N = 4,523
|
Male
N = 3,439
|
Female
N = 1,084
|
P
a
|
||
---|---|---|---|---|---|
Age, mean ± SD (years)
|
31.03 ± 5.93
|
31.19 ± 5.85
|
30.53 ± 6.17
|
<0.0001
|
|
Year, N (%)
|
2001
|
585 (12.93)
|
430 (12.50)
|
155 (14.30)
|
0.0344
|
2002
|
553 (12.23)
|
415 (12.07)
|
138 (12.73)
|
||
2003
|
551 (12.18)
|
433 (12.59)
|
118 (10.89)
|
||
2004
|
589 (13.02)
|
456 (13.26)
|
133 (12.27)
|
||
2005
|
611 (13.51)
|
462 (13.43)
|
149 (13.75)
|
||
2006
|
563 (12.45)
|
438 (12.74)
|
125 (11.53)
|
||
2007
|
537 (11.87)
|
383 (11.14)
|
154 (14.21)
|
||
2008
|
534 (11.81)
|
422 (12.27)
|
112 (10.33)
|
||
Hip fracture, N (%)
|
Trochanteric
|
1931 (42.69)
|
1580 (45.94)
|
351 (32.38)
|
<0.0001
|
Cervical
|
2592 (57.31)
|
1859 (54.06)
|
733 (67.62)
|
||
Operation, N (%)
|
Internal fixation
|
4363 (96.46)
|
3313 (96.34)
|
1050 (96.86)
|
0.4125
|
Hemiarthroplasty
|
160 (3.54)
|
126 (3.66)
|
34 (3.14)
|
||
Charlson score, N (%)
|
0
|
4110 (90.87)
|
3103 (90.23)
|
1007 (92.9)
|
0.0267
|
1
|
267 (5.90)
|
219 (6.37)
|
48 (4.43)
|
||
≥2
|
146 (3.23)
|
117 (3.40)
|
29 (2.68)
|
||
Any comorbidity, N (%)
|
|||||
Hypertension
|
116 (2.56)
|
102 (2.96)
|
14 (1.28)
|
0.0024
|
|
Diabetes mellitus
|
102 (2.26)
|
85 (2.48)
|
17 (1.56)
|
0.0807
|
|
Heart disease
|
50 (1.11)
|
38 (1.11)
|
12 (1.10)
|
0.9955
|
|
Chronic pulmonary disease
|
58 (1.28)
|
47 (1.37)
|
11 (1.01)
|
0.3692
|
|
Chronic liver disease
|
181 (4.00)
|
165 (4.81)
|
15 (1.37)
|
<.0001
|
|
Chronic renal disease
|
45 (1.00)
|
30 (0.88)
|
15 (1.37)
|
0.1390
|
|
Cerebrovascular disease
|
44 (0.98)
|
34 (1.00)
|
10 (0.92)
|
0.0807
|
|
Cancer
|
102 (2.26)
|
57 (1.65)
|
46 (4.22)
|
<.0001
|
Incidence (95 % CI)
a
|
Mortality (95 % CI)
b
|
SMR(95 % CI)
c
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Overall
|
Male
|
Female
|
Overall
|
Male
|
Female
|
Overall
|
Male
|
Female
|
|
2001
|
7.68(7.06–8.30)
|
11.09(10.04–12.13)
|
4.15(3.49–4.80)
|
1.37(0.43–2.31)
|
1.86(0.58–3.14)
|
0.00(0.00–0.00)
|
9.06(8.82–9.30)
|
10.32(10.02–10.62)
|
0.00(0.00–0.00)
|
2002
|
7.25(6.65–7.86)
|
10.70(9.67–11.73)
|
3.69(3.07–4.30)
|
1.45(0.45–2.44)
|
1.93(0.60–3.25)
|
0.00(0.00–0.00)
|
9.82(9.56–10.08)
|
11.04(10.72–11.36)
|
0.00(0.00–0.00)
|
2003
|
7.24(6.64–7.85)
|
11.19(10.14–12.24)
|
3.16(2.59–3.73)
|
1.81(0.70–2.93)
|
1.85(0.58–3.12)
|
1.69(0.00–4.02)
|
11.42(11.14–11.70)
|
10.07(9.77–10.37)
|
24.67(23.77–25.57)
|
2004
|
7.77(7.15–8.40)
|
11.84(10.75–12.92)
|
3.57(2.96–4.18)
|
1.19(0.31–2.06)
|
1.32(0.27–2.36)
|
0.75(0.00–2.22)
|
7.27(7.05–7.49)
|
6.86(6.62–7.10)
|
11.42(10.85–11.99)
|
2005
|
8.10(7.46–8.75)
|
12.06(10.96–13.16)
|
4.02(3.37–4.66)
|
1.31(0.41–2.21)
|
1.30(0.27–2.33)
|
1.34(0.00–3.19)
|
8.39(8.16–8.62)
|
7.00(6.76–7.24)
|
20.83(20.10–21.56)
|
2006
|
7.52(6.90–8.15)
|
11.54(10.46–12.62)
|
3.39(2.80–3.99)
|
0.89(0.11–1.66)
|
0.68(0.00–1.46)
|
1.60(0.00–3.80)
|
5.73(5.53–5.93)
|
3.78(3.60–3.96)
|
25.66(24.77–26.55)
|
2007
|
7.23(6.62–7.84)
|
10.18(9.16–11.20)
|
4.20(3.54–4.87)
|
1.12(0.23–2.01)
|
1.31(0.17–2.44)
|
0.65(0.00–1.92)
|
8.19(7.95–8.43)
|
7.78(7.50–8.06)
|
11.03(10.51–11.55)
|
2008
|
7.23(6.61–7.84)
|
11.29(10.21–12.37)
|
3.07(2.50–3.63)
|
0.94(0.12–1.75)
|
0.95(0.02–1.87)
|
0.89(0.00–2.64)
|
6.71(6.49–6.93)
|
5.89(5.66–6.12)
|
15.04(14.32–15.76)
|
P
d
|
0.6519
|
0.9885
|
0.5415
|
0.0464
|
0.0094
|
0.2806
|
0.0781
|
0.0241
|
0.2043
|
Mortality(%)
b
|
SMR
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N
a
|
1-year
|
2-year
|
3-year
|
5-year
|
10-year
|
1-year
|
2-year
|
3-year
|
5-year
|
10-year
|
||
Total
|
||||||||||||
Total
|
4,523
|
1.28
|
2.44
|
3.54
|
5.32
|
10.50
|
8.33
|
7.59
|
7.28
|
6.39
|
5.82
|
|
Male
|
3,439
|
1.45
|
2.69
|
3.98
|
6.13
|
12.02
|
7.82
|
6.91
|
6.83
|
6.13
|
5.54
|
|
Female
|
1,084
|
0.74
|
1.65
|
2.13
|
2.69
|
5.32
|
12.90
|
13.57
|
11.24
|
8.66
|
8.20
|
|
20–24 years
|
||||||||||||
Total
|
961
|
0.21
|
0.62
|
1.05
|
1.63
|
2.32
|
2.75
|
4.17
|
4.30
|
3.49
|
3.42
|
|
Male
|
687
|
0.14
|
0.58
|
1.03
|
1.83
|
2.09
|
0.00
|
2.46
|
2.81
|
2.61
|
2.29
|
|
Female
|
274
|
0.36
|
0.73
|
1.09
|
1.09
|
2.96
|
18.05
|
13.69
|
12.67
|
8.52
|
9.95
|
|
25–29 years
|
||||||||||||
Total
|
959
|
0.93
|
1.24
|
1.93
|
3.51
|
9.27
|
7.66
|
5.27
|
5.60
|
6.09
|
5.26
|
|
Male
|
723
|
1.10
|
1.24
|
2.14
|
3.89
|
10.27
|
7.53
|
4.31
|
5.19
|
5.62
|
4.95
|
|
Female
|
236
|
0.42
|
1.26
|
1.26
|
2.33
|
5.96
|
8.68
|
13.00
|
8.93
|
9.89
|
7.79
|
|
30–34 years
|
||||||||||||
Total
|
1,075
|
1.48
|
2.96
|
4.05
|
5.58
|
11.86
|
10.15
|
9.54
|
8.33
|
6.94
|
6.35
|
|
Male
|
846
|
1.53
|
3.29
|
4.41
|
5.93
|
13.05
|
9.17
|
9.16
|
8.02
|
6.58
|
5.98
|
|
Female
|
229
|
1.31
|
1.75
|
2.67
|
4.30
|
4.30
|
20.32
|
13.50
|
11.62
|
10.73
|
10.16
|
|
35–39 years
|
||||||||||||
Total
|
1,528
|
2.02
|
3.97
|
5.76
|
8.56
|
15.53
|
8.84
|
8.07
|
7.90
|
6.80
|
6.22
|
|
Male
|
1,183
|
2.35
|
4.37
|
6.51
|
10.13
|
18.29
|
8.80
|
7.46
|
7.53
|
6.74
|
6.13
|
|
Female
|
345
|
0.86
|
2.59
|
3.18
|
3.18
|
6.17
|
9.26
|
13.77
|
11.42
|
7.39
|
6.94
|